BioCentury
ARTICLE | Clinical News

GLPG0974: Phase I started

October 29, 2012 7:00 AM UTC

Galapagos began a double-blind, placebo-controlled, Belgian Phase I trial to evaluate multiple ascending-doses of oral GLPG0974 for 2 weeks in 32 healthy volunteers. ...